Moneyta · stock research · no sign-up needed
DHR
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q2 FY2026)
$6.3B
+9.1% y/y
Net income (Q2 FY2026)
$870M
as filed with the SEC
Institutions holding
2,120
-67 last quarter
Overview · DANAHER CORP /DE/
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment…
Management team
- Ms. Georgeann F. Couchara · Senior Vice President of Human ResourcesFind on LinkedIn
- Mr. Brian W. Ellis J.D. · Senior VP, General Counsel & Chief Compliance OfficerFind on LinkedIn
- Dr. Jose-Carlos Gutierrez-Ramos Ph.D. · Senior VP & Chief Science OfficerFind on LinkedIn
- Mr. Matthew R. McGrew · CFO & Executive VPFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on DHR
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.